PLoS ONE (Jan 2023)

Advanced gynecological cancer: Quality of life one year after diagnosis.

  • Björg Jónsdóttir,
  • Anna Wikman,
  • Inger Sundström Poromaa,
  • Karin Stålberg

DOI
https://doi.org/10.1371/journal.pone.0287562
Journal volume & issue
Vol. 18, no. 6
p. e0287562

Abstract

Read online

ObjectiveGynaecological cancer treatment impacts women's physical and psychological health. Our objective was to examine quality of life (QoL) in women with advanced gynaecological cancer at diagnosis and one year later, and to identify sociodemographic and clinical characteristics associated with QoL.MethodsWomen with endometrial, ovarian or cervical cancer treated in Uppsala, Sweden 2012-2019 were included. FIGO stage ≥II was considered advanced gynaecological cancer, whereas women in FIGO stage I were used as a control group. QoL was assessed with SF-36. We obtained information on sociodemographic and clinical characteristics from medical records and health questionnaires. Differences in QoL domains were tested with t-tests, a mixed model ANOVA and multiple linear regression analyses.ResultsThe study population (n = 372) included 150 (40.3%) women with advanced gynaecological cancer. At diagnosis, women with advanced cancer reported lower physical (71.6 vs 81.8 (mean) pConclusionWomen with advanced gynaecological cancer have equally good QoL one year after diagnosis as women with limited disease. Women with previous psychiatric illness and high BMI, are at risk of impaired physical and mental health.